These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 27973767)

  • 1. New Advances in Nanotechnology-Based Diagnosis and Therapeutics for Breast Cancer: An Assessment of Active-Targeting Inorganic Nanoplatforms.
    Falagan-Lotsch P; Grzincic EM; Murphy CJ
    Bioconjug Chem; 2017 Jan; 28(1):135-152. PubMed ID: 27973767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to Clinic.
    Bayda S; Hadla M; Palazzolo S; Riello P; Corona G; Toffoli G; Rizzolio F
    Curr Med Chem; 2018; 25(34):4269-4303. PubMed ID: 29284391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into the unique functionality of inorganic micro/nanoparticles for versatile ultrasound theranostics.
    Qian X; Han X; Chen Y
    Biomaterials; 2017 Oct; 142():13-30. PubMed ID: 28719818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inorganic nanoparticles for predictive oncology of breast cancer.
    Yezhelyev M; Yacoub R; O'Regan R
    Nanomedicine (Lond); 2009 Jan; 4(1):83-103. PubMed ID: 19093898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomedicine as a multimodal therapeutic paradigm against cancer: on the way forward in advancing precision therapy.
    Sandbhor P; Palkar P; Bhat S; John G; Goda JS
    Nanoscale; 2024 Mar; 16(13):6330-6364. PubMed ID: 38470224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of Silica-Based Micro/Nanoplatforms for Ultrasound Theranostic Biomedicine.
    Zhou Y; Han X; Jing X; Chen Y
    Adv Healthc Mater; 2017 Sep; 6(18):. PubMed ID: 28795530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redox-responsive theranostic nanoplatforms based on inorganic nanomaterials.
    Han L; Zhang XY; Wang YL; Li X; Yang XH; Huang M; Hu K; Li LH; Wei Y
    J Control Release; 2017 Aug; 259():40-52. PubMed ID: 28288893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspectives and potential applications of nanomedicine in breast and prostate cancer.
    Liu Y; Solomon M; Achilefu S
    Med Res Rev; 2013 Jan; 33(1):3-32. PubMed ID: 23239045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inorganic Nanoparticles for Image-Guided Therapy.
    Yoon HY; Jeon S; You DG; Park JH; Kwon IC; Koo H; Kim K
    Bioconjug Chem; 2017 Jan; 28(1):124-134. PubMed ID: 27788580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inorganic nanoparticles in diagnosis and treatment of breast cancer.
    Núñez C; Estévez SV; Del Pilar Chantada M
    J Biol Inorg Chem; 2018 May; 23(3):331-345. PubMed ID: 29453558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymeric nanomaterials-based theranostic platforms for triple-negative breast cancer (TNBC) treatment.
    Reddy Baddam S; Ganta S; Nalla S; Banoth C; Vudari B; Akkiraju PC; Srinivas E; Tade RS
    Int J Pharm; 2024 Jul; 660():124346. PubMed ID: 38889853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theranostic Aspects: Treatment of Cancer by Nanotechnology.
    Sarkar B; Paira P
    Mini Rev Med Chem; 2018; 18(11):969-975. PubMed ID: 29189149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging inorganic nanomaterials for pancreatic cancer diagnosis and treatment.
    Yang F; Jin C; Subedi S; Lee CL; Wang Q; Jiang Y; Li J; Di Y; Fu D
    Cancer Treat Rev; 2012 Oct; 38(6):566-79. PubMed ID: 22655679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How can nanotechnology help the fight against breast cancer?
    Avitabile E; Bedognetti D; Ciofani G; Bianco A; Delogu LG
    Nanoscale; 2018 Jul; 10(25):11719-11731. PubMed ID: 29917035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The promise of nanotechnology for solving clinical problems in breast cancer.
    Grobmyer SR; Morse DL; Fletcher B; Gutwein LG; Sharma P; Krishna V; Frost SC; Moudgil BM; Brown SC
    J Surg Oncol; 2011 Mar; 103(4):317-25. PubMed ID: 21337565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging advances in cancer nanotheranostics with graphene nanocomposites: opportunities and challenges.
    Rahman M; Akhter S; Ahmad MZ; Ahmad J; Addo RT; Ahmad FJ; Pichon C
    Nanomedicine (Lond); 2015; 10(15):2405-22. PubMed ID: 26252175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted nanoparticles for image-guided treatment of triple-negative breast cancer: clinical significance and technological advances.
    Miller-Kleinhenz JM; Bozeman EN; Yang L
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(6):797-816. PubMed ID: 25966677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosylated nanoplatforms: From glycosylation strategies to implications and opportunities for cancer theranostics.
    Zare I; Zirak Hassan Kiadeh S; Varol A; Ören Varol T; Varol M; Sezen S; Zarepour A; Mostafavi E; Zahed Nasab S; Rahi A; Khosravi A; Zarrabi A
    J Control Release; 2024 Jul; 371():158-178. PubMed ID: 38782062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inorganic nanoparticles for cancer imaging and therapy.
    Huang HC; Barua S; Sharma G; Dey SK; Rege K
    J Control Release; 2011 Nov; 155(3):344-57. PubMed ID: 21723891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of iron oxide nanoparticles in glioma imaging and therapy: from bench to bedside.
    Liu H; Zhang J; Chen X; Du XS; Zhang JL; Liu G; Zhang WG
    Nanoscale; 2016 Apr; 8(15):7808-26. PubMed ID: 27029509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.